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ABSTRACT
Delta is a major transmembrane ligand for Notch
receptor that mediates numerous cell fate deci-
sions. The Notch signaling pathway has long been
thought to be mono-directional, because ligands
for Notch were generally believed to be unable to
transmit signals into the cells expressing them.
However, we showed here that Notch also supplies
signals to neighboring mouse neural stem cells
(NSCs). To investigate the Notch–Delta signaling
pathway in a bi-directional manner, we analyzed
functional roles of the intracellular domain of mouse
Delta like protein 1 (Dll1IC). In developing mouse
NSCs, Dll1IC, which is released from cell membrane
by proteolysis, is present in the nucleus.
Furthermore, we screened for transcription factors
that bind to Dll1IC and demonstrated that Dll1IC
binds specifically to transcription factors involved
in TGF-b/Activin signaling—Smad2, Smad3 and
Smad4—and enhances Smad-dependent transcrip-
tion. In addition, the results of the present study
indicated that over-expression of Dll1IC in embryo-
nic carcinoma P19 cells induced neurons, and
this induction was blocked by SB431542, which
is a specific inhibitor of TGF-b/Activin signaling.
These observations strongly suggested that
Dll1IC mediates TGF-b/Activin signaling through
binding to Smads and plays an important role
for bi-directional Notch–Delta signaling pathway.
INTRODUCTION
Delta is a major transmembrane ligand for Notch
receptor and plays an important role in Notch signaling,
which mediates the fates of numerous cells in both
invertebrates and vertebrates (1,2). The Notch signaling
pathway has long been thought to be mono-directional,
because ligands for Notch were generally considered
unable to transmit signals into the cells expressing these
ligands (3,4). Several lines of evidence support this idea.
For example, it was thought that none of the intracellular
domains of putative Notch ligands display any signiﬁcant
sequence similarity throughout evolution (3). Indeed,
replacement of most of the intracellular domain
of LAG-2, a C. elegans lin-12 (Notch) ligand, with a
b-galactosidase fusion protein has no discernible eﬀect on
LAG-2 function (3). In contrast, however, Baker and
Schubiger reported that the extracellular domain of Notch
expressed in the mesoderm provided a positive signal to
the overlaying ectoderm in Drosophila (5). Furthermore,
it has been reported that the intracellular domain of
Delta (X-Delta-1) is required for normal development in
Xenopus (6). In Drosophila, it was also shown that
intracellular domains of these ligands act as antagonists
of Notch signaling (7). These ﬁndings suggest that
signaling in the opposite direction also exists. Thus,
the important and critical question is whether signaling
events occur not only from ligand-expressing cells
to Notch-expressing cells but also vice versa, i.e. in a
bi-directional manner.
Evidence has recently been accumulating in support of
a functional role of the intracellular domains of Notch
ligands, which implies the existence of bi-directional
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to be cleaved by ADAM protease and g-secretase to
release an intracellular domain (8–11). This processing
followed a mechanism of regulated intramembrane
proteolysis (RIP), which was ﬁrst described for the
proteolytic activation of Notch (12). The RIP mechanism
requires sequential cleavage steps to occur within the
juxtamembrane (JM) and transmembrane (TM) domain,
which are carried out by an ADAM protease and
Presenilin g-secretase, respectively. In the case of
Notch, RIP serves to release an intracellular domain
that has activity in the nucleus through binding to
transcription factors, Suppressor of Hairless (SU[H],
RBP-jk in mammals) (1,2). Indeed, several groups have
reported evidence of the nuclear localization of the
intracellular fragments of ligands for Notch (10,11,13).
Recently, it was demonstrated that many single
transmembrane-spanning proteins including Notch,
Delta and amyloid precursor protein (APP) are substrates
for g-secretase (14). Thus, it is likely that the intracellular
domains of these substrates are released from the
cell membrane by RIP. Common enzymes modulate
proteolysis and the turnover of possible signaling
molecules has led to the attractive speculation that similar
mechanisms widely contribute to proteolysis-regulated
signaling pathways (12,14).
Recently, Delwig et al. have reported that Drosophila
Delta proteolysis diﬀers from the conventional RIP,
because TM processing of Drosophila Delta is not sensitive
to preseniline, and TM and JM cleavages occur indepen-
dently of each other. Based on these observations, they
concluded that Delta proteolysis can act to modulate
Delta activity (15). However, mouse and rat Delta like
protein1 (Dll1) are sequentially processed and preseniline
is essential for these proteolysis (10,11). Thus, they adhere
more closely to the RIP mechanism. Therefore, it is
possible that the intracellular domain of Delta plays a role
in bi-directional signaling.
Indeed, Delta homologs display signiﬁcant sequence
similarity, which is restricted to vertebrates, in their
intracellular domain. We show here evidence that the
development of neurons from mouse neural stem
cells (NSCs) was enhanced by co-culture with Notch1-
expressing cells. We further demonstrated that, in devel-
oping mouse NSCs, Dll1 is already cleaved and an
intracellular domain of Dll1 (Dll1IC) is present in the
nucleus. Additionally, Dll1 proteolysis can be upregulated
through interaction with Notch1 and this upregulation
was strongly inhibited by the g-secretase inhibitor.
We also demonstrated the possibility that Dll1IC
mediates transforming growth factor-b (TGF-b)/Activin
signaling through binding to Smads, and boosts
transcription of speciﬁc genes. Finally, we showed that
over-expression of Dll1IC in embryonic carcinoma P19
cells induced neurons, and this induction was blocked
by SB431542, a speciﬁc inhibitor of TGF-b/Activin
signaling. These observations strongly suggested that
Dll1IC mediates TGF-b/Activin signaling through
binding to Smads, and plays an important role in the
bi-directional Notch–Delta signaling pathway.
MATERIALS AND METHODS
Preparation ofanti-Dll1IC Antibody
Dll1IC (nucleotides 1702–2166) was cloned into the pGEX
vector (Amersham Biosciences, New Jersey). GST fusion
protein was induced in Escherichia coli strain BL21 with
1mM IPTG and puriﬁed by glutathione aﬃnity column
chromatography (Amersham). Rabbit antisera were pre-
pared by eight subcutaneous injections of 500mg of GST
fusion protein with Freund’s adjuvant at weekly intervals.
Recombinant Dll1IC protein was released from the GST
fusion protein by digestion with thrombin and coupled to
a HiTrap aﬃnity column (Amersham). Anti-Dll1IC anti-
body was puriﬁed using this aﬃnity column. As shown in
Supplementary Figure 1S, this antibody is speciﬁc for
Dll1.
Preparation ofNSCs and subcellular proteinfractions
Pregnant mice (Crj: CD-1) were purchased from Charles
River Japan (Japan). The enzymatic method used for
preparation of NSCs from mouse embryonic day-10 (E10)
embryos and culture conditions were described previously
(16,17). For immunocytochemical study, 6 10
4 NSCs
were cultured on Poly-L-Lysin coated cell-disk
(Sumitomo, Japan), in a 1:1 mixture of Ham’s nutrient
mixture F12 and Dulbecco’s modiﬁed Eagle’s medium
(DME/F12, Invitrogen, California), supplemented with
bFGF (5ng/ml; Pepro Tech, United Kingdom) and N2
supplement (Invitrogen). N-[ N-(3,5- Diﬂuorophenacetyl-
L- alanyl)]-S- phenylglycine t-Butyl Ester (DAPT) was
purchased from Calbiochem (Germany) as a g-secretase
inhibitor (18,19). For inhibition experiments, 10mM
DAPT was added to culture medium.
Subcellular protein fractions were prepared using
FractionPREP
TM Cell Fraction System (BioVision,
California) according to manufacture’s protocol.
Culture ofNSCs on monolayer of Notch1-expressing
orDll1-expressing COS7 cells
Eight hundred nanograms of each expression vector for
full-length Notch1, full-length Dll1 or vector alone were
transfected into 8 10
4 COS7 cells using Lipofectamine
(Invitrogen) and cultured for 48h on cell-disk (Sumitomo)
as a monolayer in DME/F12 (Invitrogen), supplemented
with bFGF (5ng/ml; Pepro Tech, United Kingdom)
and N2 supplement (Invitrogen). Then 2 10
4 NSCs
were further cultured on the monolayer of COS7 cells
for 2 or 4 days followed by immunocytochemistry.
Co-culture of Dll1-expressing cells with
Notch1-expressing cells
COS7 cells were cultured in DMEM with 10% fetal calf
serum (FCS). Six micrograms of each expression vector
for full-length Notch1, full-length Dll1 or vector alone
were transfected into 10
6 COS7 cells using FuGENE6
(Roche Diagnostics, Indiana, USA). Forty-eight hours
after transfection, cells were peeled oﬀ the dish using
0.53mM EDTA in phosphate buﬀer saline (PBS).
Aliquots of 5 10
4 Dll1-expressing cells and 4 10
5
Notch1-expressing cells were mixed and cultured in
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5 cells carrying vector alone were
also mixed with 5 10
4 Dll1-expressing cells and cultured
as a control. Two days before transfection, 10mM DAPT
was added to culture medium as a g-secretase inhibitor for
inhibition experiments. Cells were disrupted and aliquots
of 20mg of cell lysates were subjected to western blotting
analysis with anti-Dll1IC antibody.
Immunocytochemistry
Cells were cultured on cell-disk (Sumitomo). After ﬁxation
with 4% paraformaldehyde in PBS for 30min, cells were
treated with 0.1% TritonX-100 and 0.1% Tween20 in PBS
for 10min, followed by blocking with 10% FCS in PBS
for 1h. Then cells were incubated with primary antibody
at 48C overnight, followed by incubation with ﬂuorescence
labeled secondary antibody. Primary antibody concentra-
tions used were as followed: rabbit anti-Dll1, 0.5ng/ml,
rabbit anti-Nestin (17), 1:1000, mouse Tuj1 (Covance,
California), 1:1000. All secondary antibodies were pur-
chased from Molecular Probes (Oregon) and the antibody
concentrations used were as followed: Alexa 546 Goat
anti-mouse IgG, 1:2000, Alexa 488 Goat anti-rabbit IgG,
1:2000, Alexa 488 Goat anti-mouse IgG, 1:2000. Nuclear
counterstaining was performed with 40, 6-diamidino-2-
phenylindole (DAPI, Molecular Probes). Signals were
visualized using Axioplan2 ﬂuorescent microscope and
AxioCam digital camera (Zeiss, Germany).
Screeningfor transcription factorsthat bindto Dll1IC
A total of 150 biotinylated double-stranded DNA
oligonucleotides representing known transcription factor
binding sequences and arrays that were spotted with
the same set of oligo DNAs (TF–TF Interaction Array)
were generously supplied by B-Bridge International Inc.
(California, USA) and Panomics (California, USA) and
used to screen for transcription factors that bind to the
intracellular domain of Dll1 protein. Detail information
about these arrays can be seen at http://panomics.com/
MA5011.cfm. Lists of oligonucleotide sequences also can
be seen at http://panomics.com/TF_TF1.cfm and http://
panomics.com/TF_TF2.cfm. NSCs were isolated from
mouse E11 embryos, and nuclear proteins were prepared
from NSCs using the Dignam method (20). Aliquots of
5mg of nuclear proteins from E11 NSCs were incubated
with 150 biotinylated double-stranded DNA oligonucleo-
tides. DNA/protein complexes including Dll1IC were
immunoprecipitated by the addition of 1mg of anti-
Dll1IC antibody and protein A-Sepharose (Amersham).
After immunoprecipitation, double-stranded DNAs were
eluted from precipitated complexes by heat treatment at
998C for 5min, followed by hybridization to the array.
Arrays were incubated with HRP-labeled Avidin and were
visualized using ECL Plus detection reagent (Amersham).
Signals were detected using a FAS1000 cooled CCD
camera (Toyobo, Japan).
Immunoprecipitation
Aliquots of 8 10
5 COS7 cells were transiently co-trans-
fected with 4mg of each cDNA encoding 8 Smads and
4mg of Dll1IC with or without 4mg of constitutively
activated receptor (caALK5-HA or caALK6-HA) using
Lipofectamine 2000 (Invitrogen). Forty-eight hours after
transfection, cells were disrupted and aliquots of 20mgo f
cell lysates were incubated with 1mg of rabbit anti-Dll1IC
antibody or 1mg of mouse monoclonal anti-FLAG M2
antibody (Sigma), followed by immunoprecipitation
and western blotting as described (21).
Establishment of Dll1ICexpressing P19 cell lines
and neuronal induction
P19 cells were cultured in alpha-modiﬁed Eagle’s essential
medium (Sigma) containing 10% FCS and
2mML-glutamine. Dll1IC expression vectors were trans-
fected into P19 cells with FuGENE6 (Roche). Cells were
also transfected with pCDNA (Invitrogen) as a negative
control. After selection of transfected P19 cells in culture
medium containing 500mg/ml of G418 for 4 weeks,
approximately twenty G418-resistant clones were picked
and analyzed for the expression of Dll1IC by western
blotting. To induce diﬀerentiation of established P19 cell
lines, cells were allowed to aggregate at 1 10
6 cells per
10-cm bacterial grade Petri dish in culture medium
without all-trans-retinoic acid (RA) for 4 days. After
aggregation, cells were plated onto poly-L-Lysine coated
cell-disk (Sumitomo). The culture medium was changed to
DME/F12 (Invitrogen) containing N2 supplement
(Invitrogen) and 10ng/ml bFGF (Pepro Tech). The cells
were cultured for 3 days to allow diﬀerentiation.
For inhibition experiments, Dll1IC-expressing P19 cells
were aggregated and plated in the presence of 1mM
SB431542 (Tocris Bioscience, Missouri, USA).
Dual Luciferase reporter assay
Aliquots of 4 10
4 HepG2 cells were transiently
transfected with the indicated amounts of expression
plasmids for Dll1IC, 100ng of 9 CAGA-Luc promoter–
reporter plasmid (22,23), which responds speciﬁcally to
Smad3, and 2ng of pRL-CMV (Promega, Wisconsin,
USA) as an internal control using FuGENE6 (Roche).
In each experiment, total amounts of plasmids were
adjusted to 0.5mg by the addition of pCDNA plasmid
(Invitrogen). After overnight incubation, 5ng/ml TGF-b
(Pepro Tech) was added to the medium for stimulation.
Aliquots of 6 10
3 Dll1IC/P19 cells or pCDNA/P19
cells were transiently transfected with 200ng of
9 CAGA-Luc promoter–reporter plasmid and 5ng of
pRL-CMV (Promega) using FuGENE6 (Roche). After
overnight incubation, cells were stimulated with TGF-b
(Pepro Tech) at various concentrations. Cell lysates were
prepared 48h after transfection, and luciferase activity
was measured using a dual-luciferase reporter system
(Promega) as described (24). Values were normalized
relative to Renilla luciferase activity.
RESULTS
Deltahomologsdisplaysignificantsequencesimilarityintheir
intracellulardomainthroughtheevolutionofvertebrates
As shown in Figure 1, amino acid sequences in the
extracellular domain of Delta are strongly conserved
914 Nucleic Acids Research, 2007, Vol. 35, No. 3through evolution. For example, amino acid identities
are 44.1% between mouse and Drosophila Delta.
Remarkably, Delta homologs share up to 70% identity
in individual EGF-like repeats. Signiﬁcant homologies
are still recognized within the intracellular domain of
vertebrate Delta. For example, in the intracellular domain,
amino acid sequence identities are 62.3% between mouse
and chicken Delta, 55.8% between mouse and Xenopus,
51.0% between mouse and zebra ﬁsh. However, there is no
homology between these vertebrate Deltas and Drosophila
Delta. Thus, conservation of amino acid sequences in
intracellular domain is restricted to vertebrate Delta. In
addition, Dll3, a divergent type of Delta, does not show
any homology to other Delta in the intracellular domain.
Three highly conserved regions are detected within
vertebrate Delta; the ﬁrst is located from amino acid
position 643 to 680, the second is located from 690 to 701
and the last is located in the C-terminus (747–781). As has
been reported, the RKRP nuclear localization signal
(747–750) and ATEV consensus PDZ-binding motif
(778–781) are present at the C-terminus region (25).
Emergence ofneurons from NSCs was enhanced by thepre-
senceof Notch
We isolated NSCs from mouse E10 embryos as described
earlier (16,17). As shown in Figure 2a and b, when NSCs
were co-cultured on a monolayer of mouse Notch1-
expressing COS7 cells for 2 days, the rate of cells positive
for Tuj1 antibody, which recognizes neuron-speciﬁc class
III b-Tubulin and is a marker of young neurons (26),
appearing from NSCs (55%) was higher than that in
control cultures (33%). This diﬀerence was statistically
signiﬁcant (P50.001) using Student’s t-test. After 4 days
of culture, many NSCs had spontaneously diﬀerentiated
into neurons (56%) in the control experiment. Although
there was no signiﬁcance by statistical analysis, more
neurons (72%) were detected in the co-culture experi-
ment with Notch1-expressing COS7 cells (Figure 2b).
Conversely, when NSCs were co-cultured for 4 days on
a monolayer of Dll1 over-expressing COS7 cells, the rate
of emergence of Tuj1 positive neurons (25%) was lower
than that in controls (56%) (Figure 2b). This diﬀerence
was also statistically signiﬁcant (P50.001).
In developing NSCs, endogenousDll1 isalready cleaved and
Dll1IC ispresent in thenucleus
To examine whether Delta was cleaved as described
previously (8–11), NSCs isolated from E10 mouse
embryos were subjected to western blotting analysis with
anti-Dll1IC antibody. As shown in Figure 3a, at least four
bands were detected on western blots. From the sizes of
the bands, band 1 seemed to be the full-length Dll1, while
the others appeared to be cleavage products of Dll1.
The band with the lowest molecular weight (band 2)
seemed like Dll1IC (18kDa) released from the cell
membrane by g-secretase (8–11). To examine the cellular
localization of Dll1IC, we prepared subcellular protein
fractions from NSCs, followed by western blotting.
Although full-length Dll1 was present in the membrane
fraction, Dll1IC was present in nuclear fraction
(Figure 3a). These results suggest that Dll1IC is localized
in the nucleus. Developing NSCs were further stained with
anti-Dll1IC antibody, a large proportion of the Dll1IC
immunoreactivity was accumulated in the nucleus as
shown in Figure 3b. These accumulations were observed
in more than 35% of developing NSCs. However,
inhibitor of g-secretase strongly blocked these accumula-
tions in almost all of NSCs (Figure 3b). These ﬁndings
indicate that a large proportion of endogenous Dll1
is already cleaved by g-secretase and activated in devel-
oping NSCs.
It has been shown that incubation of Drosophila
Delta-expressing S2 cells with Notch-expressing S2 cells
caused a transient accumulation of C-terminal fragments
of Delta that had been cleaved by latent proteases (13,15).
We therefore investigated whether mouse Dll1 processing
could also be induced through interaction with Notch.
Since COS7 cells express presenilin and have a g-secretase
activity (27,28), we employed COS7 cells for this experi-
ment. Dll1-expressing COS7 cells were co-cultured with
Notch1-expressing COS7 cells or control COS7 cells and
Dll1 processing was detected by western blotting with
anti-Dll1IC antibody. As shown in Figure 4, several bands
were detected on western blots. From the size of band,
90kDa protein seemed to be the full-length Dll1, while
the others appeared to be the cleavage products of Dll1.
When Dll1 expressing COS7 cells (Dll1/COS7) were
co-cultured with COS7 cells carrying vector alone
(CTRL/COS7) for 8h, a small amount of cleavage
products of Dll1 were initially detected. However,
cleavage products of Dll1 were remarkably increased
by co-culture with Notch1-expressing COS7 cells (Notch/
COS7). For example, even after a 1h incubation, weak
bands were detected. Thereafter, amounts of cleaved
products increased. As shown in Figure 4, this enhance-
ment of Dll1processing was strongly inhibited by DAPT
which is an inhibitor for g-secretase.
Dll1ICbound toSmads andenhanced Smad depending
transcription
The nuclear localization of Dll1IC suggests that Dll1IC
may have eﬀects on the transcriptions of speciﬁc target
genes. To examine this possibility, we searched for
transcription factors capable of binding to Dll1IC using
a new method. Brieﬂy (see Supplementary Figure 2S),
nuclear extracts from E11 NSCs were incubated with 150
double-stranded DNA oligonucleotides representing bind-
ing sequences of known transcription factors.
After immunoprecipitation with an antibody against
Dll1IC, double-stranded oligos were eluted from the
precipitated complexes and hybridized to arrays that
were spotted with the same set of oligos in duplicate.
The hybridization signals obtained are shown in
Figure 5a. The Smad binding sequences (50-AGTATGT
CTAGACTGA-30) showed strong signals, which
were enhanced by the addition of recombinant Dll1IC to
nuclear extracts prior to immunoprecipitation (Figure 5b).
Two spots, signals of which were enhanced by the addition
of recombinant Dll1IC protein, were Pax-5 binding
sequence and mineral corticoid response element (MRE).
Nucleic Acids Research, 2007, Vol. 35,No. 3 915Figure 1. Alignment of amino acid sequences of Delta homologs from various vertebrate species and Drosophila was generated using DNASIS
program (Hitachi Software, Japan). Amino acids that are identical to those of mouse Dll1 are shown in black. Amino acids that diﬀer from those
of mouse Dll1 are shown in red. Gaps that were introduced for the alignment are shown as lines. The transmembrane region is shaded gray.
RKRP predicted nuclear localization signal is shaded yellow, ATEV PDZ-binding motif is shaded green. M-Dll1: mouse Delta1, C-Dll1: chicken
Delta1, X-Dll1: Xenopus Delta1, Z-Dll1: zebra ﬁsh DeltaD, D-D: Drosophila Delta, M-Dll3: mouse Delta3.
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addition of recombinant Dll1IC protein, were NF-kB
binding site and NF-E2 binding sequence.
These ﬁndings suggest that Dll1IC forms complexes with
Smads in the nucleus of NSCs. Thus,
co-immunoprecipitation experiments were performed to
conﬁrm these results. FLAG-tagged Smad cDNAs were
transfected along with Dll1IC into COS7 cells and
cell extracts were subjected to immunoprecipitation
with anti-FLAG or anti-Dll1IC antibody followed by
western blotting (Figure 5c). Eight vertebrate Smads,
designated Smad1 to Smad8, have been identiﬁed to date
(29,30). Although Smad1 and Smad5 did not bind
to Dll1IC, Smad2 and Smad3 showed strong binding.
Co-transfection with caALK5-HA or caALK6-HA,
an expression vector for the constitutively active receptor
that phosphorylates Smad2, Smad3 and Smad1, Smad 5,
Smad 8, respectively did not show any signiﬁcant
eﬀects on binding. Smad4 also showed strong binding to
Dll1IC. Smad6, Smad7 and Smad8 showed weak binding
to Dll1IC.
Next, we examined the eﬀects of Dll1IC on Smad-
dependent transcription. We performed dual luciferase
assay using 9 CAGA-Luc promoter–reporter plasmids
that respond speciﬁcally to Smad3 (22,23). These
promoter–reporter plasmids were transfected into
HepG2 cells with or without Dll1IC expression vector.
After transfection, the cells were stimulated with or
without TGF-b, and luciferase activities were measured
as an indicator of transcriptional activity. As shown
in Figure 6a, only a little activity was detected without
TGF-b stimulation, regardless of whether Dll1IC
Figure 2. Co-culture of NSCs with Notch1-expressing cells or Dll1-
expressing cells. (a) NSCs were cultured for 2 days on monolayers of
Dll1 (2) or Notch1 (3) over-expressing COS7 cells and immunostained
with Tuj1, a marker of neurons (red) and the NSC marker Nestin
(green). (1): Control experiment with pCDNA-transfected COS7 cells.
(b) NSCs were co-cultured for two (black bar: 2days diﬀ.) or four
(white bar: 4days diﬀ.) days as described above. After immunostaining,
Tuj1-positive neurons and Nestin-positive NSCs were counted. Values
are means S.D. for 10 independent ﬁelds.***P50.001, Student’s t-test
(versus appropriate controls).
Figure 3. Dll1 was cleaved and Dll1IC presented in the nucleus.
(a) Aliquots of 20mg of lysates from NSCs and aliquots of 30mgo f
subcellular protein fractions were subjected to western blotting with
anti-Dll1IC antibody. From the sizes of the bands, band 1 seemed to be
the full-length mouse Delta (Dll1), while the others appeared to be
cleavage products of Dll1. The band with the lowest molecular weight
(band 2) seemed like Dll1IC (18kDa) released from the cell membrane.
S, lysates from NSCs; N, nuclear fraction; C, cytoplasm fraction;
M, membrane fraction. (b) NSCs were stained with anti-Dll1IC
antibody (1) and DAPI (2). Merged image (3) shows that immunor-
eactivity had accumulated in the nucleus. However, inhibitor of
g-secretase strongly blocked these accumulations; stained with
anti-Dll1IC antibody (4), DAPI (5), merged image (6).
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HepG2 cells with TGF-b signiﬁcantly induced transcrip-
tional activity from this promoter, and expression of
Dll1IC further enhanced the transcriptional activity in a
dose-dependent manner. For example, co-transfection of
100 and 400ng of Dll1IC expression vectors were
associated with a 175 and 250% enhancement of luciferase
activity respectively as compared with TGF-b stimulation
alone (Figure 6a).
We established P19 cells stably over-expressing Dll1IC
(Dll1IC/P19). P19 cells, which carry the vector alone
(pCDNA/P19), were also established and used as control.
9 CAGA-Luc promoter–reporter plasmids were trans-
fected into Dll1IC/P19 or pCDNA/P19. After transfec-
tion, cells were stimulated with TGF-b at various
concentrations and luciferase activities were measured.
No signiﬁcant diﬀerence of luciferase activity was detected
between Dll1IC/P19 and control without TGF-b stimula-
tion (Figure 6b). However, stimulation of these cells
with TGF-b made signiﬁcant diﬀerence of luciferase
activity between Dll1IC/P19 and control cells. In brief,
stimulation of Dll1IC/P19 with 0.5 and 1ng/ml TGF-b
were associated with 180 and 220% enhancement of
luciferase activity respectively as compared with
control cells (Figure 6b).
Over-expression ofDll1IC inembryonic carcinoma
P19 cellsinduced neurons
Dll1IC may be involved in neuronal diﬀerentiation
through binding to Smads. To examine this possibility,
we employed Dll1IC/P19 as well as pCDNA/P19 as
controls.
Figure 4. Co-culture of Dll1-expressing cells with Notch1-expressing
cells. Each expression vector for full-length Notch1, full-length Dll1 or
vector alone was transfected into COS7 cells. Forty-eight hours
after transfection, Dll1-expressing cells (Dll1/COS7) were mixed with
Notch-expressing cells (Notch/COS7) or control cells (CTRL/COS7) at
a ratio of 1:8 and cultured for indicated times. DAPT was added to the
culture medium as an inhibitor of g-secretase. Dll1 processing was
detected by western blotting with anti-Dll1IC antibody. From the size
of the band, the 90kDa protein (top band) seemed to be full-length
Dll1, while the other appeared to be cleaved products of Dll1. Cleavage
products of Dll1 were remarkably increased by co-culture with Notch1-
expressing COS7 cells and these increases were strongly inhibited by
DAPT. The same ﬁlter was also reacted with anti-G3PDH antibody
as an internal control, showing that almost the same amount of cell
lysates were processed for western blotting (bottom of the ﬁgure).
Figure 5. Dll1IC bound to Smad2, Smad3 and Smad4. (a) Result of
screening for transcription factors that bind to Dll1IC. Note that Smad
binding sequences showed strong signals (boxed). (b) Signal from Smad
binding sequences (boxed) were enhanced by the addition of
recombinant Dll1IC protein to the nuclear extract before immuno-
precipitation. Signals from Pax-5 binding sequence and mineral
corticoid response element (MRE) were also enhanced by the addition
of recombinant Dll1IC protein. On the other hand, signals from NF-kB
binding site and NF-E2 binding sequence were disappeared by the
addition of recombinant Dll1IC protein. Spots along the right and
bottom side of arrays are markers for alignment. (c) COS7 cells were
transiently co-transfected with each expression vector for 8 Smads and
Dll1IC expression vector with or without expression vectors for
constitutive activated receptor (caALK5-HA or caALK6-HA). Forty-
eight hours after transfection, lysates from co-transfected COS7 cells
were subjected to immunoprecipitation (IP) with the indicated
antibodies, followed by western blotting (WB). Dll1IC, rabbit
anti-Dll1IC antibody; Flag, mouse monoclonal anti-FLAG M2
antibody. Levels of expression of Smads and Dll1IC were determined
by western blotting and are shown in the bottom two panels.
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is essential for the induction of neurons from P19 cells
(31–34). Thus, Dll1IC/P19 and pCDNA/P19 were cul-
tured as aggregates for 4 days without RA, and then
plated onto coverslips where the cells were allowed to
diﬀerentiate for 3 days. Although pCDNA/P19 retained
epithelial cell-like morphology, Dll1IC/P19 cells became
round and showed a bipolar morphology with neurite
extension (Figure 7a). pCDNA/P19 cells were negative for
Tuj1, a marker of neurons, while almost all Dll1IC/P19
cells were Tuj1-positive (Figure 7a). These results indicate
that over-expression of Dll1IC in P19 cells induced
neurons. However, when 1mM SB431542, a speciﬁc
inhibitor of the TGF-b type1 receptor that activates
Smad2 and Smad3 by phosphorylation (35–37), was
added to Dll1IC/P19 cultures, the appearance of neurons
was strongly inhibited. For example, Dll1IC/P19 treated
with SB431542 retained epithelial cell-like morphology
similar to pCDNA/P19 (Figure 7a). Although a few cells
had long neurites, less than 10% of the cells were positive
for Tuj1 (Figure 7a). These ﬁndings were conﬁrmed
by western blotting. As described above, Dll1IC/P19 and
pCDNA/P19 were cultured without RA, allowed to
diﬀerentiate, and lysates were prepared from subcultured,
aggregated and re-plated cells, then subjected to western
blotting with Tuj1 antibody. As shown in Figure 7b,
expression of Tuj1 protein was induced after diﬀerentia-
tion of Dll1IC/P19. Moreover, SB431542 strongly
inhibited this induction and there were no changes
detected in pCDNA/P19 throughout the culture period
(Figure 7b).
DISCUSSION
As indicated above, the important question is whether
signaling events occur not only from ligand-expressing
cells to Notch-expressing cells but also vice versa, i.e. in
a bi-directional manner. As shown in Figure 1, up to 50%
homologies are still recognized within the intracellular
domain through the evolution of vertebrates. Thus, it is
highly possible that conservation of these amino acid
sequences reﬂect the functional importance of the
intracellular domain. Indeed, we show here evidence that
Dll1IC plays an important role in a bi-directional
signaling pathway. Since the conservation of these
sequences is restricted to vertebrate Delta, it seems that
these functions, which are discussed below, would be
common to vertebrates, but not invertebrates.
Invertebrate DeltaIC may have a diﬀerent function from
that in vertebrates.
As shown in Figure 2, when NSCs were co-cultured
on a monolayer of Dll1-expressing COS7 cells, the rate of
emergence of neurons was lower than that in controls.
It is well known that Notch signaling helps maintain
the undiﬀerentiated state of NSCs and inhibits the
determination of neurons (1,2). Our ﬁndings therefore
suggest that Dll1 on COS7 cells generates signals to
neighboring NSCs that express Notch and thus
activates Notch signaling. Conversely, when NSCs were
co-cultured on a monolayer of mouse Notch1-expressing
COS7 cells for 2 days, the rate of neurons developing from
NSCs (55%) was signiﬁcantly (P50.001) higher than
that in control cultures (33%) (Figure 2a and b).
These observations indicate that Notch1 on COS7 cells
may also generate signals to neighboring NSCs and these
ligands, probably Delta, may then transmit signals
into the cells expressing them to mediate neuronal
diﬀerentiation. Thus, signaling events may occur not
only from Delta-expressing cells to Notch-expressing cells
but also vice versa, that is, in a bi-directional manner,
during diﬀerentiation of NSCs. The Drosophila mosaic
Figure 6. Dll1IC enhanced Smad-dependent transcription. (a) HepG2
cells were transiently transfected with the indicated amounts of Dll1IC
expression vector and 9 CAGA-Luc promoter–reporter plasmid,
which responds speciﬁcally to Smad3. Cells were stimulated by the
addition of TGF-b to the medium. Luciferase activities were normal-
ized using the pRL-CMV vector that was always co-transfected as an
internal control. Values are shown as the means S.D. of four
independent experiments. (b)9  CAGA-Luc promoter–reporter plas-
mid was transfected into P19 cells stably over-expressing Dll1IC
(Dll1IC/P19). P19 cells, which carry the vector alone (pCDNA/P19),
were used as control. After transfection, cells were stimulated with
TGF-b at various concentrations. Luciferase activities were normalized
using the pRL-CMV vector that was always co-transfected as an
internal control. Values are shown as the means S.D. of four
independent experiments.
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published some data from a mosaic experiment in
Drosophila, showing that expression of Notch in the
mesoderm of Notch mutant could suppress the ectodermal
defects of the mutant (5). This eﬀect was inferred to be due
to the extracellular domain of the protein and not its
signaling function, since activated Notch failed to produce
non-autonomous suppression (5). This suggested that the
extracellular domain of Notch expressed in mesoderm was
acting as a positive signal to the overlaying ectoderm in
Drosophila.
It has been reported that Delta is cleaved sequentially
by proteases, including ADAM and g-secretase (8–11)
and processing of Drosophila Delta was up-regulated
in co-cultures with Notch-expressing S2 cells (13,15).
It has also been reported that a truncated intracellular
isoform of Delta shows prominent nuclear localization
(10,11,13). Thus, we examined whether the same events
occurred in mouse NSCs. Indeed, in developing NSCs,
a large proportion of endogenous Dll1 is already cleaved
and Dll1IC was localized in the nucleus (Figure 3a).
Immunoreactivity against Dll1IC was accumulated in the
nucleus and inhibitor of g-secretase strongly blocked
this accumulation (Figure 3b). Moreover, co-culture
experiment showed that Dll1 processing could be
enhanced through interaction with Notch1 (Figure 4).
This enhancement was strongly inhibited by g-secretase
inhibitor (Figure 4). Although, as indicated in the
introduction, Delwig et al. reported that Drosophila
Delta proteolysis diﬀers from the conventional RIP (15),
mouse and rat Dll1 adhere more closely to RIP
mechanism. Because, mouse and rat Dll1 are sequentially
processed and preseniline is essential for these proteolysis
(10,11). Thus, these observations further support the idea
that signaling event also occurred from Notch-expressing
cells to Delta-expressing cells.
The nuclear localization of Dll1IC suggests that Dll1IC
may have eﬀects on the transcriptions of speciﬁc target
genes. To examine this possibility, we searched for
transcriptional factors capable of binding to Dll1IC
using a new method (see Supplementary Figure 2S).
Since Smad binding sequence showed a strong signal
(Figure 5a and b), co-immunoprecipitation experiments
were performed to conﬁrm these ﬁndings. Smads
have been shown to act as mediators of signaling by the
TGF-b superfamily. Eight vertebrate Smads, designated
Smad1 to Smad8, have been identiﬁed to date (29,30).
Smad2 and Smad3 are activated by TGF-b and activin
(21,38,39), while Smad1 and Smad5 are major compo-
nents that are activated by bone morphogenic proteins
(BMPs) (40–42). Although Smad1 and Smad5 did not
bind to Dll1IC, Smad2 and Smad3 showed strong binding
(Figure 5c). These ﬁndings suggest that Dll1IC mediates
TGF-b/Activin signaling through binding to Smad2
and/or Smad3. Phosphorylation of Smad2 and Smad3
was not required for binding to Dll1IC, as co-transfection
with caALK5-HA, an expression vector for the constitu-
tively active receptor that phosphorylates Smad2 and
Smad3, did not show any signiﬁcant eﬀects on binding
(Figure 5c). However, BMP signaling, which is known
to inhibit neurogenesis and to enhance the appearance
of astrocytes (43,44), may not be aﬀected by Dll1IC,
as Dll1IC did not bind to Smad1 or Smad5. Although
Smad8 is thought to be involved in BMP signaling,
it showed only weak binding to Dll1IC (Figure 5c).
The common Smad, Smad4, which ubiquitously forms
heterotrimeric complexes with two other Smads (41,45),
also showed strong binding to Dll1IC (Figure 5c).
Thus, binding of Dll1IC to not only Smad2 and Smad3
but also to Smad4 may stabilize Dll1IC–Smad complexes.
Smad6 and Smad7 are thought to be inhibitory Smads.
Smad7 inhibits both TGF-b/Activin signaling and BMP
signaling, whereas Smad6 preferentially inhibits BMP
signaling (30). Although interactions between Dll1IC
and these inhibitory Smads were weak, it is interesting
if these interaction can inhibit BMP signaling, which is
known to inhibit neurogenesis and to enhance the
appearance of astrocytes (43,44).
Although we have yet to determine the actual target
genes for the Dll1IC complex with Smad2 or Smad3, we
performed dual luciferase assay using 9 CAGA-Luc
promoter–reporter plasmids that respond speciﬁcally to
Smad3 (22,23) as a model system. As shown in Figure 6a,
stimulation of HepG2 cells with TGF-b signiﬁcantly
induced transcriptional activity from this promoter and
expression of Dll1IC further enhanced the activity in a
dose-dependent manner. These ﬁndings strongly suggest
that Dll1IC mediates transcription of certain genes, which
are targets of TGF-b/Activin signaling, through binding
to Smads. As shown in Figure 6b, similar transfection
experiments using P19 cells stably over-expressing
Figure 7. Over-expression of Dll1IC in P19 cells induced neurons.
(a) Dll1IC-expressing P19 cells (Dll1IC/P19) and those carrying vector
alone (pCDNA/P19) were cultured without RA. For inhibition
experiments, Dll1IC/P19 cells were cultured with 1mM SB431542.
(1)–(3) are phase-contrast micrographs, and (4)–(6) show the results
of staining with Tuj1, a marker of neurons (red) and DAPI (blue).
(b) Cells were cultured as described and lysates were prepared
from subcultured cells (1), aggregated cells (2) and re-plated cells (3).
Aliquots of 10mg of lysates were subjected to western blotting
with Tuj1.
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transcriptional activity and support this conclusion.
Interestingly, Pﬁster et al. identiﬁed the PDZ protein,
Acvrinp1 as a binding protein to mouse Dll1IC (25).
Acvrinp1 also interacts with Activin Type II receptors and
Smad3 (46). Thus, it is likely that Dll1IC can already join
in assembling signaling molecules at a subcellular site,
then translocate to the nucleus with Smads.
Dll1IC may be involved in neuronal diﬀerentiation
through binding to Smads. To examine this possibility, we
employed Dll1IC/p19 again. Although P19 cells have been
shown to be induced to diﬀerentiate into neurons (31–34),
RA stimulation is essential for the induction of neurons
from P19 cells. However, neurons could be induced from
P19 cells stably over-expressing Dll1IC without RA
stimulation and this induction was strongly inhibited by
SB431542, a speciﬁc inhibitor of TGF-b type1 receptor
that activates Smad2 and Smad3 (Figure 7a and b).
Expressions of TGF-bs and their receptors were detected
through the diﬀerentiation of P19 cells (Supplementary
Figure 3S). These results indicate that over-expression of
Dll1IC in P19 cells induced neurons through binding to
Smad2 and/or Smad3, suggesting that Dll1IC plays an
important role in neuronal diﬀerentiation. Recently, it has
been reported that TGF-b inhibits proliferation and
accelerates diﬀerentiation of hippocampal granule
neuron (47). This observation also supports our
hypothesis.
These observations lead us to conclude (see schematic
model in Supplementary Figure 4S) that the Notch
receptor also supplies signals to Delta that are expressed
on the surface of neighboring NSCs. Delta is then cleaved
sequentially by proteases, probably including ADAM
and g-secretase (8–11), and ﬁnally Dll1IC is released from
the cell membrane and translocates to the nucleus, where
it mediates TGF-b/Activin signaling through binding
to Smads and enhances transcription of speciﬁc genes
leading to neuronal diﬀerentiation. This conclusion
strongly implies the existence of Delta signaling, which
means that the Notch-Delta signaling pathway is
bi-directional. It is well known that the intracellular
domain of Notch is also released from the cell membrane
by the RIP mechanism (1,2,12,14) similar to those
involved in the cleaving of Delta and translocates to the
nucleus to modulate gene expression through binding to
the transcription factor, Suppressor of Hairless (SU[H],
RBP-jk in mammals) (1,2). Therefore, similar mechanisms
are involved in both directions of the Notch–Delta
signaling pathway.
In the view of a bidirectional signaling pathway, it
would be interesting to see if Delta pathway antagonizes
Notch pathway. As a pilot experiment, we have examined
if Dll1IC is able to regulate the Notch target genes by
luciferase assay. However, we could not detect any
antagonized or agonized activity of Dll1IC against
expression of Hes1 or Hes5 genes as shown in
Supplementary Figure 5S.
BMPs, another group belonging to the TGF-b super-
family, have recently been shown to inhibit neurogenesis
and to enhance the generation of astrocytes from NSCs
(43,44). It is thus likely that the TGF-b superfamily
mediates both neurogenesis and gliogenesis from neural
stem cells.
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